易尚展示(002751.SZ)一季度預盈1500萬-2000萬元
格隆匯 4 月 13日丨易尚展示(002751.SZ)公佈,預計2021年第一季度歸屬於上市公司股東的淨利潤1500萬元-2000萬元,同比增長16585.21%-22146.94%。
上年同期由於新冠疫情爆發影響,公司經營業績基數較低;隨着國內疫情的有效防控,市場需求迅速恢復,公司生產經營已恢復正常,訂單量呈現良好的發展態勢。公司適時調整經營策略,加大市場拓展力度,重點開拓新零售、電子煙、白酒、汽車等領域的市場需求,2021年第一季度公司業務預計同比有較大增長。
報吿期內,公司預計非經常性損益對淨利潤影響金額約1100萬元,主要為政府補助。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.